Home LiteratureArticle Details
PMID: 22056457 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Consistent multi-time-point brain atrophy estimation from the boundary shift integral.

NeuroImage ·Vol. 59 ·No. 4 ·2012-02-15 ·Pages 3995-4005

Leung KK, Ridgway GR, Ourselin S, Fox NC, Alzheimer's Disease Neuroimaging Initiative

Abstract

Brain atrophy measurement is increasingly important in studies of neurodegenerative diseases such as Alzheimer's disease (AD), with particular relevance to trials of potential disease-modifying drugs. Automated registration-based methods such as the boundary shift integral (BSI) have been developed to provide more precise measures of change from a pair of serial MR scans. However, when a method treats one image of the pair (typically the baseline) as the reference to which the other is compared, this systematic asymmetry risks introducing bias into the measurement. Recent concern about potential biases in longitudinal studies has led to several suggestions to use symmetric image registration, though some of these methods are limited to two time-points per subject. Therapeutic trials and natural history studies increasingly involve several serial scans, it would therefore be useful to have a method that can consistently estimate brain atrophy over multiple time-points. Here, we use the log-Euclidean concept of a within-subject average to develop affine registration and differential bias correction methods suitable for any number of time-points, yielding a longitudinally consistent multi-time-point BSI technique. Baseline, 12-month and 24-month MR scans of healthy controls, subjects with mild cognitive impairment and AD patients from the Alzheimer's Disease Neuroimaging Initiative are used for testing the bias in processing scans with different amounts of atrophy. Four tests are used to assess bias in brain volume loss from BSI: (a) inverse consistency with respect to ordering of pairs of scans 12 months apart; (b) transitivity consistency over three time-points; (c) randomly ordered back-to-back scans, expected to show no consistent change over subjects; and (d) linear regression of the atrophy rates calculated from the baseline and 12-month scans and the baseline and 24-month scans, where any additive bias should be indicated by a non-zero intercept. Results indicate that the traditional BSI processing pipeline does not exhibit significant bias due to its use of windowed sinc interpolation, but with linear interpolation and asymmetric registration, bias can be pronounced. Either improved interpolation or symmetric registration alone can greatly reduce this bias, and our proposed method combining both aspects shows no significant bias in any of the four experiments.

MeSH Terms
Aged Alzheimer Disease/pathology Atrophy Brain/pathology Cognitive Dysfunction/pathology Humans Image Processing, Computer-Assisted Magnetic Resonance Imaging Time Factors
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Leung Kelvin K
Dementia Research Centre, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK. [email protected]
Ridgway Gerard R
Ourselin Sébastien
Fox Nick C
Alzheimer's Disease Neuroimaging Initiative
Article Info
Journal
NeuroImage
Abbr.
Neuroimage
ISSN
1095-9572
Published
2012-02-15
Epub
2011-00-28
Pages
3995-4005
Language
English
Region
United States
NLM ID
9215515
Subset
IM
Grants
Department of Health · United Kingdom
NIA NIH HHS · U01 AG024904 · United States
NIA NIH HHS · K01 AG030514 · United States
Medical Research Council · G0601846 · United Kingdom
NIA NIH HHS · P30 AG010129 · United States
Medical Research Council · G0801306 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]